Migratory Activity of CD105+ Pancreatic Cancer Cells Is Strongly Enhanced by Pancreatic Stellate Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Migratory Activity of CD105+ Pancreatic Cancer Cells Is Strongly Enhanced by Pancreatic Stellate Cells

Published:2013-11 Issue:8 Volume:42 Page:1283-1290
ISSN:0885-3177
Container-title:Pancreas
language:en
Short-container-title:

Author:

Fujiwara Kenji,Ohuchida Kenoki,Ohtsuka Takao,Mizumoto Kazuhiro,Shindo Koji,Ikenaga Naoki,Cui Lin,Takahata Shunichi,Aishima Shinichi,Tanaka Masao

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference36 articles.

1. Pancreatic cancer.;Vincent;Lancet,2011

2. Current status of surgery for pancreatic cancer.;Hirata;Dig Surg,2007

3. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).;Corsini;J Clin Oncol,2008

4. Adjuvant and neoadjuvant approaches to treat surgically resectable pancreatic cancer.;Keedy;Curr Treat Options Oncol,2006

5. Stem cells, cancer, and cancer stem cells.;Reya;Nature,2001

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Listeria-based immunotherapy directed against CD105 exerts anti-angiogenic and anti-tumor efficacy in renal cell carcinoma;Frontiers in Immunology;2022-11-11

2. Endoglin in the Spotlight to Treat Cancer;International Journal of Molecular Sciences;2021-03-20

3. Derivation and Validation of the Potential Core Genes in Pancreatic Cancer for Tumor-Stroma Crosstalk;BioMed Research International;2018-11-05

4. The prognostic correlation between CD105 expression level in tumor tissue and peripheral blood and sunitinib administration in advanced hepatocellular carcinoma;Cancer Biology & Therapy;2018-09-05

5. 5-FU resistant EMT-like pancreatic cancer cells are hypersensitive to photochemical internalization of the novel endoglin-targeting immunotoxin CD105-saporin;Journal of Experimental & Clinical Cancer Research;2017-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3